RxDoctor Payments DataLook up a doctor →

Robert Orr, DO

Pulmonary Disease · Peoria, AZNPI 1003809930

Payments from drug & device makers

$1,589,538in general payments, 2019–2025

Across 819 payments — averaging $1940.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$490K
  • Merck$307K
  • AbbVie$281K
  • Novo Nordisk AS$116K
  • Astute Medical, Inc.$108K
  • AstraZeneca$46K
  • plus $240K from 53 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Vanda Pharmaceuticals Inc.66$490,427
Merck28$307,492
AbbVie57$280,580
Novo Nordisk AS33$115,858
Astute Medical, Inc.24$108,495
AstraZeneca46$46,275
Sanofi US Services Inc.14$42,174
GSK113$40,744
Boehringer Ingelheim31$34,066
Teva Pharmaceuticals USA, Inc.10$25,099
Boehringer Ingelheim Pharma GmbH & Co.kg2$17,211
Hikma Pharmaceuticals USA2$15,500
Harmony Biosciences LLC24$13,264
Genentech, Inc.9$11,014
Hoffmann-la Roche Limited1$10,000
Novartis15$8,588
Lexicon Pharmaceuticals, Inc.1$7,331
Insmed, Inc.31$5,103
Kowa Research Institute, Inc.2$3,254
Sanofi46$1,216
Regeneron Healthcare Solutions, Inc.39$954
Electromed, Inc.53$482
Medical Graphics Corporation1$410
Jazz Pharmaceuticals Inc.9$330
Baxter Healthcare14$302
Mylan Specialty L.p.13$301
Grifols USA, LLC20$293
Genentech USA, Inc.15$291
Sanofi-aventis U.S. LLC3$254
Verona Pharma, Inc.8$244
Philips North America LLC11$213
Actelion Pharmaceuticals US, Inc.8$204
Inspire Medical Systems, Inc.4$141
United Therapeutics Corporation6$124
Takeda Pharmaceuticals U.S.A., Inc.4$123
Avadel CNS Pharmaceuticals, LLC6$116
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC6$101
ANI Pharmaceuticals, Inc.3$99
Sunovion Pharmaceuticals Inc.4$75
Amgen3$73
Pfizer4$73
Inogen, Inc.5$72
Vifor Pharma, Inc.2$66
Pulmonx Corporation3$53
Novo Nordisk1$51
Viatris Specialty LLC2$51
Vapotherm Inc1$44
Lilly USA, LLC2$43
Phadia US Inc.2$40
Abbott2$35
Lucid Diagnostics Inc.2$30
Advanced Respiratory, Inc1$29
Boston Scientific1$25
Nestle Healthcare Nutrition Inc.1$25
Eisai Inc.1$20
Bayer1$18
Optos, Inc.1$16
Shire North American Group Inc1$14
Tactile Systems Technology Inc1$13

How this compares

$1,589,538 in reported general payments places this provider in the 95th percentile of 250 pulmonary disease providers in Arizona.

See all pulmonary disease providers in Arizona →

Medicare billing

Part B allowed, 2024
$282,433
Medicare patients
624
Services billed
3,284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Peoria

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →